Latest PERCEPTIVE ADVISORS LLC Stock Portfolio
PERCEPTIVE ADVISORS LLC Performance:
2024 Q3: 16.41%YTD: 12.34%2023: 18.41%
Performance for 2024 Q3 is 16.41%, and YTD is 12.34%, and 2023 is 18.41%.
About PERCEPTIVE ADVISORS LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, PERCEPTIVE ADVISORS LLC reported an equity portfolio of $4.7 Billions as of 30 Sep, 2024.
The top stock holdings of PERCEPTIVE ADVISORS LLC are ACLX, NUVL, FOLD. The fund has invested 6.9% of it's portfolio in ARCELLX INC and 6.4% of portfolio in NUVALENT INC.
The fund managers got completely rid off CEREVEL THERAPEUTICS HLDNG I (CERE), MADRIGAL PHARMACEUTICALS INC (MDGL) and BRIDGEBIO PHARMA INC (BBIO) stocks. They significantly reduced their stock positions in NEUROCRINE BIOSCIENCES INC (NBIX), ADMA BIOLOGICS INC (ADMA) and NATERA INC (NTRA). PERCEPTIVE ADVISORS LLC opened new stock positions in INSULET CORP (PODD), ORUKA THERAPEUTICS INC and DYNE THERAPEUTICS INC (DYN). The fund showed a lot of confidence in some stocks as they added substantially to ARGENX SE, VERONA PHARMA PLC (VRNA) and VIKING THERAPEUTICS INC (VKTX).
The top stock holdings of PERCEPTIVE ADVISORS LLC are ACLX, NUVL, FOLD. The fund has invested 6.9% of it's portfolio in ARCELLX INC and 6.4% of portfolio in NUVALENT INC.
The fund managers got completely rid off CEREVEL THERAPEUTICS HLDNG I (CERE), MADRIGAL PHARMACEUTICALS INC (MDGL) and BRIDGEBIO PHARMA INC (BBIO) stocks. They significantly reduced their stock positions in NEUROCRINE BIOSCIENCES INC (NBIX), ADMA BIOLOGICS INC (ADMA) and NATERA INC (NTRA). PERCEPTIVE ADVISORS LLC opened new stock positions in INSULET CORP (PODD), ORUKA THERAPEUTICS INC and DYNE THERAPEUTICS INC (DYN). The fund showed a lot of confidence in some stocks as they added substantially to ARGENX SE, VERONA PHARMA PLC (VRNA) and VIKING THERAPEUTICS INC (VKTX).
PERCEPTIVE ADVISORS LLC Annual Return Estimates Vs S&P 500
Our best estimate is that PERCEPTIVE ADVISORS LLC made a return of 16.41% in the last quarter. In trailing 12 months, it's portfolio return was 42.19%.
New Buys
| Ticker | $ Bought |
|---|---|
| insulet corp | 33,113,100 |
| oruka therapeutics inc | 30,274,400 |
| dyne therapeutics inc | 25,795,700 |
| adagio med hldgs inc | 25,316,000 |
| instil bio inc | 23,262,100 |
| zenas biopharma inc | 19,357,100 |
| xencor inc | 10,611,500 |
| roivant sciences ltd | 9,782,980 |
New stocks bought by PERCEPTIVE ADVISORS LLC
Additions
| Ticker | % Inc. |
|---|---|
| argenx se | 661 |
| verona pharma plc | 159 |
| viking therapeutics inc | 135 |
| orchestra biomed hldgs inc | 80.39 |
| viridian therapeutics inc | 72.36 |
| axsome therapeutics inc | 70.51 |
| eyepoint pharmaceuticals inc | 62.00 |
| centessa pharmaceuticals plc | 59.72 |
Additions to existing portfolio by PERCEPTIVE ADVISORS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| neurocrine biosciences inc | -67.34 |
| adma biologics inc | -61.74 |
| natera inc | -58.49 |
| springworks therapeutics inc | -58.12 |
| bicycle therapeutics plc | -55.25 |
| crinetics pharmaceuticals in | -50.91 |
| medtronic plc | -50.00 |
| tyra biosciences inc | -49.25 |
PERCEPTIVE ADVISORS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cerevel therapeutics hldng i | -441,402,000 |
| vbi vaccines inc cda | -832,728 |
| bridgebio pharma inc | -30,784,700 |
| ars pharmaceuticals inc | -7,380,880 |
| engene holdings inc | -7,544,000 |
| recursion pharmaceuticals in | -5,769,220 |
| cullinan therapeutics inc | -13,078,500 |
| revance therapeutics inc | -1,542,000 |
PERCEPTIVE ADVISORS LLC got rid off the above stocks
Sector Distribution
PERCEPTIVE ADVISORS LLC has about 84.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 84.4 |
| Others | 15.6 |
Market Cap. Distribution
PERCEPTIVE ADVISORS LLC has about 3.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 51.7 |
| SMALL-CAP | 26.8 |
| UNALLOCATED | 15.6 |
| LARGE-CAP | 3.4 |
| MICRO-CAP | 2.4 |
Stocks belong to which Index?
About 66.2% of the stocks held by PERCEPTIVE ADVISORS LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 64.4 |
| Others | 33.8 |
| S&P 500 | 1.8 |
PERCEPTIVE ADVISORS LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC has 102 stocks in it's portfolio. About 46.1% of the portfolio is in top 10 stocks. VRCA proved to be the most loss making stock for the portfolio. ACLX was the most profitable stock for PERCEPTIVE ADVISORS LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.06 | 700,000 | 2,674,000 | unchanged | 0.00 | ||
| ACLX | arcellx inc | 6.87 | 3,888,670 | 324,743,000 | reduced | -0.03 | ||
| ADMA | adma biologics inc | 0.45 | 1,060,200 | 21,193,400 | reduced | -61.74 | ||
| AGLE | spyre therapeutics inc | 1.79 | 2,872,550 | 84,481,600 | reduced | -5.23 | ||
| AKRO | akero therapeutics inc | 1.04 | 1,714,810 | 49,197,800 | added | 14.33 | ||
| ALDX | aldeyra therapeutics inc | 1.06 | 9,275,850 | 49,996,800 | unchanged | 0.00 | ||
| ALLO | allogene therapeutics inc | 0.16 | 2,725,000 | 7,630,000 | unchanged | 0.00 | ||
| AMLX | amylyx pharmaceuticals inc | 0.15 | 2,125,650 | 6,887,100 | new | |||
| AORT | artivion inc | 1.57 | 2,793,700 | 74,368,400 | unchanged | 0.00 | ||
| APLT | applied therapeutics inc | 1.44 | 8,005,000 | 68,042,500 | unchanged | 0.00 | ||
| ARQT | arcutis biotherapeutics inc | 0.27 | 1,358,500 | 12,634,000 | reduced | -12.83 | ||
| ARVN | arvinas inc | 0.54 | 1,027,750 | 25,313,500 | unchanged | 0.00 | ||
| ATHA | athira pharma inc | 0.05 | 5,402,960 | 2,409,720 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 1.51 | 6,485,420 | 71,404,500 | unchanged | 0.00 | ||
| AXGN | axogen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 1.49 | 782,844 | 70,354,200 | added | 70.51 | ||
| BBIO | bridgebio pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCYC | bicycle therapeutics plc | 0.12 | 255,994 | 5,793,140 | reduced | -55.25 | ||
| BDSX | biodesix inc | 0.08 | 2,173,880 | 3,869,510 | unchanged | 0.00 | ||
| CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||